Cancer Research Institute shared a post on LinkedIn:
“Cancer Research Institute is proud to announce the 2026 class of Lloyd J. Old STARs– five bold scientists pushing the boundaries of immunotherapy and reimagining what’s possible in the fight against cancer.
Rooted in CRI’s exceptional track record of identifying and supporting people who have had a major impact in immunotherapy, these grants are not tied to a specific research project, but rather support outstanding researchers based on the quality and promise of their overall work.
‘These are people who are hitting their stride scientifically and career-wise, and this is where you really want to put some jet fuel in the tank,’
describes CRI Scientific Advisory Council Associate Director, Dr. E. John Wherry, of Penn Medicine, University of Pennsylvania Health System.
Discover how their fearless ideas are reshaping the future of treatment.”
Other articles about Cancer Research Institute on OncoDaily.
